Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

News · May 21, 2023

Racial, Ethnic Differences ID'd in Receipt of Meds to Treat Opioid Use Disorder

More White than Black and Hispanic patients receive buprenorphine, naloxone, benzodiazepines in 180 days after index event



Further Reading